BrightSpring Health Services Touts 2026 Growth, EBITDA $760M-$790M at TD Cowen Health Care Conference

March 7, 2026 - 06:22

Executives from BrightSpring Health Services recently detailed a confident growth trajectory, forecasting significant financial expansion over the coming years. During a presentation at a major healthcare investment conference, company leadership emphasized expectations for broad-based growth coupled with increased profitability.

Chief Financial Officer Jennifer Phipps highlighted several key drivers behind this optimistic outlook. She pointed to consistent volume growth across the company's diverse service lines, ongoing initiatives to enhance operational efficiency, and the strategic benefits of recent acquisitions. These factors are collectively expected to fuel margin expansion and strengthen the company's financial foundation.

The company provided specific financial targets for 2026, projecting Adjusted EBITDA to reach between $760 million and $790 million. This forecast underscores management's belief in the durability of their business model and the continued demand for BrightSpring's essential pharmacy and provider services. The presentation reinforced the company's focus on executing its strategic plan to deliver value and support for the patients and healthcare partners it serves across the nation.